Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird

Endocrinol Nutr. 2014 Dec;61(10):501-4. doi: 10.1016/j.endonu.2014.11.002.
[Article in English, Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Obesity Agents / therapeutic use*
  • Appetite Depressants / therapeutic use*
  • Benzazepines / therapeutic use
  • Bupropion / administration & dosage
  • Bupropion / therapeutic use
  • Clinical Trials as Topic
  • Drug Approval
  • Drug Combinations
  • Europe / epidemiology
  • Fructose / administration & dosage
  • Fructose / analogs & derivatives
  • Fructose / therapeutic use
  • Humans
  • Naltrexone / administration & dosage
  • Naltrexone / therapeutic use
  • Obesity / drug therapy*
  • Obesity / epidemiology
  • Phentermine / administration & dosage
  • Phentermine / therapeutic use
  • Product Surveillance, Postmarketing
  • Topiramate
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Obesity Agents
  • Appetite Depressants
  • Benzazepines
  • Drug Combinations
  • Bupropion
  • Topiramate
  • Fructose
  • Naltrexone
  • lorcaserin
  • Phentermine